Ubs Asset Management Americas Inc Tg Therapeutics, Inc. Transaction History
Ubs Asset Management Americas Inc
- $381 Billion
- Q3 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 293,927 shares of TGTX stock, worth $9.85 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
293,927
Previous 321,874
8.68%
Holding current value
$9.85 Million
Previous $5.73 Million
20.05%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding TGTX
# of Institutions
338Shares Held
87.7MCall Options Held
2.35MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA15.4MShares$515 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$382 Million0.0% of portfolio
-
State Street Corp Boston, MA9.09MShares$305 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.58MShares$120 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA3.21MShares$107 Million0.01% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.87B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...